Merck said on Wednesday that its experimental oral HIV treatment was not inferior to Gilead's top-selling HIV drug Biktarvy ...

Merck reports positive results from phase 3 trial of once-daily, oral, two-drug, single-tablet regimen of Doravirine/Islatravir in treatment-naïve adults with HIV-1 infection ...

New diagnoses of HIV and syphilis have doubled in Florida since 2020. St. Lucie County has the highest rate of new HIV cases ...

Last year, 444 people in the Netherlands were diagnosed with HIV, the virus that can cause AIDS. Almost 20 years ago, there ...

THERE’S been an “alarming” increase in HIV infections among straight women, a new report warns. It comes as sexual health ...

Despite effective HIV medication, the immune system of people with HIV remains disrupted in the long term.

The first gene-editing therapies for HIV/Aids are entering trials but the virus is proving once again that it is a master at ...

Despite effective HIV medication, the immune system of people with HIV remains disrupted in the long term. Researchers at ...

Merck said on Wednesday that its experimental oral HIV treatment met the main goal of a late-stage trial. The company said ...

Opportunistic infections target people with weakened immune systems, including those with HIV. These conditions can lead to ...

In people with HIV infection aged 60 years or older, the long-acting cabotegravir and rilpivirine combination maintains high ...

Women are disproportionately affected by HIV, making up nearly half of new infections globally and in India. Stigma, gender ...